Qube Research & Technologies Ltd - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 57 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$25,813
-62.2%
9,890
-68.4%
0.00%
Q1 2023$68,254
-86.8%
31,309
-26.9%
0.00%
-100.0%
Q4 2022$515,257
+175.5%
42,831
+48.7%
0.00%
+200.0%
Q3 2022$187,000
-23.0%
28,795
-45.8%
0.00%
-50.0%
Q2 2022$243,000
-50.1%
53,128
-5.7%
0.00%
-50.0%
Q1 2022$487,000
-47.4%
56,348
-13.0%
0.00%
-42.9%
Q4 2021$925,000
+320.5%
64,799
+294.9%
0.01%
+133.3%
Q2 2021$220,000
-4.3%
16,407
-69.8%
0.00%0.0%
Q4 2020$230,000
+16.8%
54,291
-28.0%
0.00%0.0%
Q3 2020$197,000
+245.6%
75,395
+365.7%
0.00%
+200.0%
Q2 2020$57,00016,1910.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 366,401$2,374,0002.07%
Private Portfolio Partners LLC 67,400$436,7520.12%
Knoll Capital Management, LLC 20,000$130,0000.08%
ETF MANAGERS GROUP, LLC 94,493$612,0000.02%
Virtu Financial LLC 21,526$139,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 21,904$142,0000.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$36,0000.01%
Walleye Capital LLC 78,418$508,0000.01%
Jump Financial, LLC 36,100$234,0000.01%
Plante Moran Financial Advisors, LLC 7,911$51,0000.01%
View complete list of ORAMED PHARMACEUTICALS INC shareholders